# Ioversol

Source: https://onco.cc/drugs/ioversol/  
OnCo record `ioversol` (Imaging agent). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A CT and angiography dye given into a vein or artery.

## Summary

Optiray (NDA 019710, Liebel-Flarsheim, first approved 30 December 1988) is indicated for intra-arterial arteriography and intravenous procedures including "Computed tomography (CT) Imaging of Head and Body", venography and excretory urography. Its boxed warning covers the risks of inadvertent intrathecal administration. ATC V08AB07.

## Fields

- Kind: Imaging agent
- Status: approved
- Last checked: 2026-11-04
- Also known as: ioversol; Optiray
- Tags: contrast-agents-gaps-2026-11; diagnostic
- Brand: Optiray
- Modality: Iodinated contrast agent for CT and angiography (intravenous, intra-arterial)
- Mechanism: A non-ionic low-osmolar iodinated molecule that makes vessels and enhancing tissues appear bright on CT and X-ray.
- Approvals: US 1988: Arteriography; CT of the head and body; venography; excretory urography

## Sources

- Drugs@FDA Optiray (NDA 019710): https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019710
- DailyMed label: Optiray: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=549d38db-d4ed-4708-8f76-7cdaa157063f
- WHO ATC index V08AB: low osmolar X-ray contrast media: https://atcddd.fhi.no/atc_ddd_index/?code=V08AB&showdescription=no

## Connected records

- technologies: [CT (computed tomography)](https://onco.cc/technologies/ct/), [Iodinated and barium contrast for CT and X-ray](https://onco.cc/technologies/iodinated-contrast-media/)

---
JSON: https://onco.cc/api/v1/entities/ioversol.json